Zydus Cadila gets USFDA nod for anti-bacterial drug

Drug firm Zydus Cadila said it had received approval from the U.S. Food & Drug Administration to market Azithromycin for Oral Suspension USP, used to treat bacterial infections, in the American market. The medication is used to treat respiratory infections, skin infections, ear infections and sexually transmitted diseases. The drug will be manufactured at the group’s formulations manufacturing facility at Baddi.

Source : https://www.thehindu.com/todays-paper/tp-business/zydus-cadila-gets-usfda-nod-for-anti-bacterial-drug/article24576849.ece

About sree nivas

Check Also

India Semiconductor Mission

India Semiconductor Mission (ISM): Building a Domestic Chip Ecosystem

Introduction The Indian government, recognizing the critical role of semiconductors in the digital age, launched …

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Free Updates to Crack the Exam!
Subscribe to our Newsletter for free daily updates